These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 36010962)

  • 1. OATD-02 Validates the Benefits of Pharmacological Inhibition of Arginase 1 and 2 in Cancer.
    Grzybowski MM; Stańczak PS; Pomper P; Błaszczyk R; Borek B; Gzik A; Nowicka J; Jędrzejczak K; Brzezińska J; Rejczak T; Güner-Chalimoniuk NC; Kikulska A; Mlącki M; Pęczkowicz-Szyszka J; Olczak J; Gołębiowski A; Dzwonek K; Dobrzański P; Zasłona Z
    Cancers (Basel); 2022 Aug; 14(16):. PubMed ID: 36010962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arginase 1/2 Inhibitor OATD-02: From Discovery to First-in-man Setup in Cancer Immunotherapy.
    Borek B; Nowicka J; Gzik A; Dziegielewski M; Jedrzejczak K; Brzezinska J; Grzybowski M; Stanczak P; Pomper P; Zagozdzon A; Rejczak T; Matyszewski K; Golebiowski A; Olczak J; Lisiecki K; Tyszkiewicz M; Kania M; Piasecka S; Cabaj A; Dera P; Mulewski K; Chrzanowski J; Kusmirek D; Sobolewska E; Magdycz M; Mucha L; Masnyk M; Golab J; Nowotny M; Nowak E; Napiorkowska-Gromadzka A; Pikul S; Jazwiec R; Dzwonek K; Dobrzanski P; Meyring M; Skowronek K; Iwanowski P; Zaslona Z; Blaszczyk R
    Mol Cancer Ther; 2023 Jul; 22(7):807-817. PubMed ID: 36939275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of arginase by CB-1158 blocks myeloid cell-mediated immune suppression in the tumor microenvironment.
    Steggerda SM; Bennett MK; Chen J; Emberley E; Huang T; Janes JR; Li W; MacKinnon AL; Makkouk A; Marguier G; Murray PJ; Neou S; Pan A; Parlati F; Rodriguez MLM; Van de Velde LA; Wang T; Works M; Zhang J; Zhang W; Gross MI
    J Immunother Cancer; 2017 Dec; 5(1):101. PubMed ID: 29254508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Androgen-regulated expression of arginase 1, arginase 2 and interleukin-8 in human prostate cancer.
    Gannon PO; Godin-Ethier J; Hassler M; Delvoye N; Aversa M; Poisson AO; Péant B; Alam Fahmy M; Saad F; Lapointe R; Mes-Masson AM
    PLoS One; 2010 Aug; 5(8):e12107. PubMed ID: 20711410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondrial arginase-2 is a cell‑autonomous regulator of CD8+ T cell function and antitumor efficacy.
    Martí i Líndez AA; Dunand-Sauthier I; Conti M; Gobet F; Núñez N; Hannich JT; Riezman H; Geiger R; Piersigilli A; Hahn K; Lemeille S; Becher B; De Smedt T; Hugues S; Reith W
    JCI Insight; 2019 Nov; 4(24):. PubMed ID: 31751318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The arginase inhibitor Nω-hydroxy-nor-arginine (nor-NOHA) induces apoptosis in leukemic cells specifically under hypoxic conditions but CRISPR/Cas9 excludes arginase 2 (ARG2) as the functional target.
    Ng KP; Manjeri A; Lee LM; Chan ZE; Tan CY; Tan QD; Majeed A; Lee KL; Chuah C; Suda T; Ong ST
    PLoS One; 2018; 13(10):e0205254. PubMed ID: 30307989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Novel Oral Arginase 1/2 Inhibitor Enhances the Antitumor Effect of PD-1 Inhibition in Murine Experimental Gliomas by Altering the Immunosuppressive Environment.
    Pilanc P; Wojnicki K; Roura AJ; Cyranowski S; Ellert-Miklaszewska A; Ochocka N; Gielniewski B; Grzybowski MM; Błaszczyk R; Stańczak PS; Dobrzański P; Kaminska B
    Front Oncol; 2021; 11():703465. PubMed ID: 34504786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endogenous arginase 2 as a potential biomarker for PEGylated arginase 1 treatment in xenograft models of squamous cell lung carcinoma.
    Lam SK; Yan S; Xu S; U KP; Cheng PN; Ho JC
    Oncogenesis; 2019 Feb; 8(3):18. PubMed ID: 30808864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel orally bioavailable piperidine derivatives as extracellular arginase inhibitors developed by a ring expansion.
    Gzik A; Borek B; Chrzanowski J; Jedrzejczak K; Dziegielewski M; Brzezinska J; Nowicka J; Grzybowski MM; Rejczak T; Niedzialek D; Wieczorek G; Olczak J; Golebiowski A; Zaslona Z; Blaszczyk R
    Eur J Med Chem; 2024 Jan; 264():116033. PubMed ID: 38096651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single Nucleotide Polymorphisms in the Arginase 1 and 2 Genes Are Differentially Associated with Circulating l-Arginine Concentration in Unsupplemented and l-Arginine-Supplemented Adults.
    Hannemann J; Rendant-Gantzberg L; Zummack J; Hillig J; Eilermann I; Böger R
    J Nutr; 2021 Apr; 151(4):763-771. PubMed ID: 33232463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repression of arginase-2 expression in dendritic cells by microRNA-155 is critical for promoting T cell proliferation.
    Dunand-Sauthier I; Irla M; Carnesecchi S; Seguín-Estévez Q; Vejnar CE; Zdobnov EM; Santiago-Raber ML; Reith W
    J Immunol; 2014 Aug; 193(4):1690-700. PubMed ID: 25009204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myeloid Cell-Derived Arginase in Cancer Immune Response.
    Grzywa TM; Sosnowska A; Matryba P; Rydzynska Z; Jasinski M; Nowis D; Golab J
    Front Immunol; 2020; 11():938. PubMed ID: 32499785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Virtual Screening for FDA-Approved Drugs That Selectively Inhibit Arginase Type 1 and 2.
    Detroja TS; Samson AO
    Molecules; 2022 Aug; 27(16):. PubMed ID: 36014374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of polymorphic variants of arginase genes (ARG1, ARG2) involved in beta-2-agonist metabolism in the development and course of asthma.
    Savelieva ON; Karunas AS; Fedorova YY; Murzina RR; Savelieva AN; Gatiyatullin RF; Etkina EI; Khusnutdinova EK
    Vavilovskii Zhurnal Genet Selektsii; 2020 Jul; 24(4):391-398. PubMed ID: 33659822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arginase 1 is a key driver of immune suppression in pancreatic cancer.
    Menjivar RE; Nwosu ZC; Du W; Donahue KL; Hong HS; Espinoza C; Brown K; Velez-Delgado A; Yan W; Lima F; Bischoff A; Kadiyala P; Salas-Escabillas D; Crawford HC; Bednar F; Carpenter E; Zhang Y; Halbrook CJ; Lyssiotis CA; Pasca di Magliano M
    Elife; 2023 Feb; 12():. PubMed ID: 36727849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Roles of arginase variants, atopy, and ozone in childhood asthma.
    Salam MT; Islam T; Gauderman WJ; Gilliland FD
    J Allergy Clin Immunol; 2009 Mar; 123(3):596-602, 602.e1-8. PubMed ID: 19281908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ARG2 impairs endothelial autophagy through regulation of MTOR and PRKAA/AMPK signaling in advanced atherosclerosis.
    Xiong Y; Yepuri G; Forbiteh M; Yu Y; Montani JP; Yang Z; Ming XF
    Autophagy; 2014; 10(12):2223-38. PubMed ID: 25484082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functionally important role for arginase 1 in the airway hyperresponsiveness of asthma.
    North ML; Khanna N; Marsden PA; Grasemann H; Scott JA
    Am J Physiol Lung Cell Mol Physiol; 2009 Jun; 296(6):L911-20. PubMed ID: 19286931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The metabolic enzyme arginase-2 is a potential target for novel immune modulatory vaccines.
    Weis-Banke SE; Hübbe ML; Holmström MO; Jørgensen MA; Bendtsen SK; Martinenaite E; Carretta M; Svane IM; Ødum N; Pedersen AW; Met Ö; Madsen DH; Andersen MH
    Oncoimmunology; 2020 Jun; 9(1):1771142. PubMed ID: 32923127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arginase 1 mediates increased blood pressure and contributes to vascular endothelial dysfunction in deoxycorticosterone acetate-salt hypertension.
    Toque HA; Nunes KP; Rojas M; Bhatta A; Yao L; Xu Z; Romero MJ; Webb RC; Caldwell RB; Caldwell RW
    Front Immunol; 2013; 4():219. PubMed ID: 23908657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.